pembrolizumab,atezolizumab,lenvatinib,tislelizumab,sorafenib,Abemaciclib
merck,beigene,roche,eli lilly,eisai,bayer,novartis
['gusm', 'immotion010', 'rationale301', 'hcc', 'leap002', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', '#gi', 'bcsm', 'rcc,(-irccs),(-srcc),(-urcc)', 'gism', 'breast']
day 2 #esmo22 highlights #communityoncology 1. #leap002 - hcc shared by 2. #rationale301 - hcc shared by 3. #adaptet - adj breast ca shared by 4. #immotion010 - adj rcc by #medtwitter #gusm #gism #bcsm 1/5
Practice changing #Oncology news from #CommunityOncologists perspective w/ Rohit Gosain @UPMCHillmanCC & Rahul Gosain @WilmotCancer. Views are our own.